C
Chromocell Therapeutics Corp
AMEX:CHRO
Chromocell Therapeutics Corp
AMEX:CHRO
Price:
22.46
USD
-5.03%
Market Closed
Market Cap:
$3.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Chromocell Therapeutics Corp
AMEX:CHRO
|
US |
|
Gyldendal A/S
CSE:GYLD B
|
DK |
|
A
|
Ageas SA
OTC:AGESY
|
BE |
|
M
|
Malin Corporation PLC
ISEQ:MLC
|
IE |
|
G
|
Grande Armee Investissement GAI SA
PAR:MLGAI
|
FR |
|
Quanta Services Inc
NYSE:PWR
|
US |
|
C
|
China Medical System Holdings Ltd
HKEX:867
|
CN |
|
Elematec Corp
TSE:2715
|
JP |
Balance Sheet
Balance Sheet Decomposition
Chromocell Therapeutics Corp
Chromocell Therapeutics Corp
Balance Sheet Decomposition is not available for
Chromocell Therapeutics Corp
Chromocell Therapeutics Corp
Balance Sheet
Chromocell Therapeutics Corp
Chromocell Therapeutics Corp
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
1
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
+75%
|
1
+1 320%
|
|
| Liabilities | ||||||
| Accounts Payable |
3
|
3
|
3
|
5
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
1
|
2
|
|
| Total Current Liabilities |
4
|
3
|
4
|
7
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
4
+1%
|
4
+2%
|
7
+74%
|
4
-38%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
4
|
6
|
14
|
21
|
|
| Additional Paid In Capital |
0
|
0
|
2
|
7
|
19
|
|
| Total Equity |
4
N/A
|
4
-3%
|
4
-1%
|
6
-74%
|
3
+58%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
+75%
|
1
+1 320%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
6
|
6
|
6
|
6
|
6
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
